Cell Therapeutics, Inc. (CTI) Readies Pixuvri® European Launch and Start of …Sacramento BeeThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing randomized con…

Cell Therapeutics, Inc. (CTI) Readies Pixuvri® European Launch and Start of …MSN MoneyThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing randomized controll…

Cell Therapeutics, Inc. (CTI) Readies Pixuvri® European Launch and Start of …MarketWatch (press release)The European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing r…

Rituxan Effective in Refractory RAMedPage TodayPatients with rheumatoid arthritis who fail on treatment with a tumor necrosis factor (TNF) inhibitor may have a better response if they switch to rituximab (Rituxan) rather than trying a second TNF blocke…

Rituximab aids remission in idiopathic membranous nephropathyNews-Medical.netBy Andrew Czyzewski, MedWire Reporter. Rituximab achieves good rates of remission in patients with persistent idiopathic membranous nephropathy (IMN), with few serious adverse…

Clinical Oncology NewsSpotlight on selected articles from the Journal of Clinical Oncology and BloodClinical Oncology NewsAnas Younes, MD; Yvette Kasamon, MD; and colleagues took advantage of the CD-20 expression in classical Hodgkin's lymphoma (cH…

Rituximab Useful in Idiopathic Membranous NephropathyDoctors LoungeFor patients with idiopathic membranous nephropathy and persistent nephrotic syndrome, rituximab treatment is associated with good rates of partial or complete remission with stabilized…

Gilead Sciences Management Discusses Q2 2012 Results – Earnings Call …Seeking AlphaThese studies in a placebo-controlled fashion compare GS-1101 added to either Rituximab or to Rituximab with Bendamustine in relapsed refractory CLL patient. My remain…

Spectrum Pharmaceuticals Announces Publication Demonstrating Enhanced …Business Wire (press release)The data, published in Blood, the journal of the American Society of Hematology, showed that addition of ZEVALIN following fludarabine, cyclophosphami…

Immune Drug Helps Patients with Serious Kidney DisorderNewswise (press release)Because the drug rituximab specifically targets immune cells involved in the development and progression of IMN, Piero Ruggenenti, MD, Giuseppe Remuzzi, MD, FRCP (Mario Negr…